Cough
📧 Sign up to get email alerts when something new happens for Cough.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2023-11-08EMA Application withdrawn: Gefzuris (gefapixant) — Merck Sharp & Dohme B.V.
The EMA reports that the application for Gefzuris (gefapixant) by Merck Sharp & Dohme B.V. has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-05-23Clinical Trial Update: Effect of Cyclodextrin on Sensory Nerve Activity: A Novel Anti-tussive Therapy [Phase 4]
A Phase 4 clinical trial investigating cyclodextrin as a novel anti-tussive therapy for cough was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-13Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Diphenhydramine + Pseudoephedrine + Dropropizine in the Control of Cough and the Relief of Nasal Symptoms, Suffering From Non-productive Cough and Acute Rhinitis [Phase 3]
A Phase 3 trial evaluating a fixed-dose combination of diphenhydramine, pseudoephedrine, and dropropizine for non-productive cough and acute…
-
CLINICAL_TRIALS withdrawal · 2012-04-20Clinical Trial Update: Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal Reflux [Phase 3]
This Phase 3 pediatric study on chronic cough and gastroesophageal reflux has been withdrawn.